Arkolith/Insider Trading/USRM/Form 4

Knutson Gregory

DirectorU.S. Stem Cell, Inc. (USRM) · full profile →Form 4 · filed Mar 25, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2022Grant(A)25.0M$0.01$250K26.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2022Grant(A)12.5M$100000.00$1.3T16.1M
Feb 24, 2022Grant(A)12.5M——28.6M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001185185-22-000329) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML